EKF Diagnostics Signs Research Deal With Massachusetts General Hospital
23rd Sep 2014 07:18
LONDON (Alliance News) - EKF Diagnostics Holdings PLC Monday said it has taken a major step towards detecting cancer cells in blood samples, and has appointed a new technology boss. Separately, EKF said it has appointed Tito Bacarese-Hamilton as its new Chief Technology Officer. Bacarese-Ha Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Tuesday its wholly-owned subsidiary, Selah Genomics Inc, has signed a agreement with a US sales firm to provide testing services for a new suite of womaen's health-focused molecular assays. The AIM-listed point-of-care, central labo Read More
LONDON (Alliance News) - Company acquisitions and disposals have roared back to the fore Tuesday, with <strong>RSA Insurance</strong>, <strong>London Stock Exchange</strong>, <strong>Wolseley</strong>, <strong>RPS</strong>, <strong>Cobham</strong> and others all making pre-market announcements Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said Michael Bolick, a divisional executive bought 91,00 shares at a price of 27.04 pence per share Monday. Following this transaction, Bolick now holds 5 million shares, which represents 1.17% stake in the firm. Shares in Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said a group of Directors and non-executives bought shares in the central laboratory and molecular diagnostics business.<br /><br />Details are as follows.<br /><br /> <table class="cy" style="width: 580px; height: 175px;" cells Read More
LONDON (Alliance News) - <strong>HSBC Holdings</strong> Wednesday reported a 20% drop in first-quarter pretax profit, driven by a weak performance Asia, Latin America and its investment bank, that was only partially offset by lower impairment charges and continued cost cutting.<br /><br />In a Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC saw its shares drop on the AIM All-Share market Wednesday after the company said reimbursement by Medicare for Selah Genomic's drug metabolism genetic biomarkers panel, has been reduced after revisions by the Medicare Administrative Contractor Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Legal & General</strong> Group, up 3.2%. The group said it expects to write more Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC saw its shares drop on the AIM All-Share market Wednesday morning as the company said reimbursement by Medicare for Selah Genomic's DME panel, has been reduced after revisions by the MAC. The point-of-care, central laboratory and molecul Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />BARCLAYS RAISES INTERCONTINENTAL HOTELS PT TO 2100 (1900) PENCE - 'EQUAL WEIGHT <br />----------<br />CREDIT SUISSE RAISES IN Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said that it had raised GBP4.0 million, before expenses, in an oversubscribed share offer. Last month, the company said it raised GBP22.0 million in a placing at 35 pence a share and said it was also looking to raise an addition Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC Thursday said it has entered into separate conditional agreements to buy US-based molecular diagnostics business Selah Genomics Inc for up to USD70.6 million and Swedish haemoglobin analysers DiaSpect Medical AB for up to GBP20.75 million. Read More
LONDON (Alliance News) - EKF Diagnostics Holdings PLC said Wednesday that it had acquired Florida-based Separation Technology Inc, which manufactures in vitro diagnostic devices, for USD4.0 million in cash. The purchase price will be satisfied out of current debt facilities, EKF said. It ex Read More
LONDON (Alliance News) - EKF Diagnostic Holdings PLC said Tuesday that it plans to transfer production of its Quo-Test and Quo-Lab analysers and reagents cartridges from its facilities in Hersham, near Walton-on-Thames, to its manufacturing site in Barleben, Germany. The biotechnology compa Read More